Drug Trial Radar · NCT02193334
Phase I/II Study of KP-100IT in Acute Spinal Cord Injury
Last checked: Nov 19, 2026Latest source record: Jun 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
45
Actual
Start
Jun 30, 2014
Primary completion
Dec 21, 2017
Study completion Jul 31, 2018
Sponsor
- Lead sponsor
- Kringle Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 17, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is randomized, double-blind, placebo-controlled Phase I/II study designed to evaluate safety and efficacy of KP-100IT, code of Hepatocyte Growth Factor (HGF) formulation for intrathecal injection, as a treatment for acute spinal cord injury. The study is conducted at two clinical sites in Japan.
Conditions
- Spinal Cord Injuries
Interventions
KP-100ITDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number and degree of adverse eventsTime frame: 24 weeks
- Change of ASIA (American Spinal Injury Association) motor score from baseline at 24 weeksTime frame: 24 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Spinal Injuries Center
Iizuka, Fukuoka, Japan
Hokkaido Chuo Rosai Hospital Sekison Center
Bibai, Hokkaido, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.